Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
International Journal of Molecular Sciences|July 13, 2024
Small Cell Lung Carcinoma Cells Depend on KIF11 for SurvivalYuji Sakuma, Sachie Hirai, Miki Yamaguchi, et al.
Experimental Cell Research|February 21, 2022
Anthrax toxin receptor 2 is a potential therapeutic target for non-small cell lung carcinoma with MET exon 14 skipping mutationsMiki Yamaguchi, Sachie Hirai, Masashi Idogawa, et al.
Biochemical and Biophysical Research Communications|April 1, 2020
EGFR-independent EGFR-mutant lung adenocarcinoma cells depend on Bcl-xL and MCL1 for survivalSachie Hirai, Makoto Tada, Miki Yamaguchi, et al.
Journal of Medical Ultrasonics (2001)|February 11, 2023
Histopathology of non-mass-like breast lesions on ultrasoundRin Yamaguchi, Hidetaka Watanabe, Yutaro Mihara, et al.
Biochemical and Biophysical Research Communications|August 24, 2023
Dual inhibition of KIF11 and BCL2L1 induces apoptosis in lung adenocarcinoma cellsYuji Sakuma, Sachie Hirai, Toshiyuki Sumi, et al.
Anticancer Research|October 30, 2016
Cell Surface Antibody Retention Influences In Vivo Antitumor Activity Mediated by Antibody-dependent Cellular CytotoxicityMasahiro Ikeda, Kazunori Kato, Miki Yamaguchi, et al.
Biochemical and Biophysical Research Communications|September 20, 2022
Dual inhibition of BCL2L1 and MCL1 is highly effective against RET fusion-positive or MET exon 14 skipping mutation-positive lung adenocarcinoma cellsSachie Hirai, Masashi Idogawa, Toshiyuki Sumi, et al.
International Journal of Molecular Sciences|August 29, 2024
A Newly Developed Anti-L1CAM Monoclonal Antibody Targets Small Cell Lung Carcinoma CellsMiki Yamaguchi, Sachie Hirai, Masashi Idogawa, et al.
Pageof 10